|
US2019084933A1
|
|
Indole derivatives for use in medicine
|
|
AU2017257377A1
|
|
Novel substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase
|
|
KR20170081204A
|
|
Pharmaceutical compound
|
|
GB201516411D0
|
|
Pharmaceutical compound
|
|
EP3182972A1
|
|
Pharmaceutical compound
|
|
GB201511790D0
|
|
Pharmaceutical compound
|
|
GB201507883D0
|
|
Pharmaceutical compound
|
|
CA2944240A1
|
|
Indole derivatives for use in medicine
|
|
GB201502156D0
|
|
Pharmaceutical compound
|
|
WO2015091862A1
|
|
Screening method
|
|
US2016367564A1
|
|
Pharmaceutical compound
|
|
GB201419570D0
|
|
Pharmaceutical compound
|
|
GB201419579D0
|
|
Pharmaceutical compound
|
|
WO2014195228A1
|
|
Screening method for a glut9 inhibitor
|
|
WO2014187922A1
|
|
Slc2a transporter inhibitors
|
